Spruce Biosciences, Inc. Common Stock (SPRB)

• Market cap: $67.2M
• 1 day: 2.21%
• 5 days: 12.6%
• 1 month: -22.38%
• 3 months: -27.41%
• 6 months: 554.9%
• Year to date: -29.24%
• 1 year: 146.85%
• 5 years: -96.2%
• 10 years: -94.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20